LN

Lena Nader Toma Attallah

Active Director Director DIN 10280499
DIN 10280499 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Lena Nader Toma Attallah

Data last updated:

Lena Nader Toma Attallah is a Director at Php For Pharmaceutical Industries Private Limited (since 2023). The company operates in Pharma.

DIN 10280499
Primary Designation Director
Industry Pharma
First Appointment 16 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Aug 20232023Active

Board colleagues of Lena Nader Toma Attallah

Directorship timeline

Open interactive timeline →
Php For Pharmaceutical Industries Private Limited
Premium access

Shareholding and investment profile for Lena Nader Toma Attallah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lena Nader Toma Attallah

Lena Nader Toma Attallah currently holds 1 directorship: Php For Pharmaceutical Industries Private Limited (Director, since 16 Aug 2023).

Lena Nader Toma Attallah was first appointed on 16 Aug 2023 as Director at Php For Pharmaceutical Industries Private Limited.

The current boards of Lena Nader Toma Attallah's companies include Daya Shankar (Php For Pharmaceutical Industries Private Limited), Michael Nabil Michaeil Eskandar (Php For Pharmaceutical Industries Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available